BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 38302473)

  • 21. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection.
    Ji F; Zhang ZH; Zhang Y; Shen SL; Cao QH; Zhang LJ; Li SQ; Peng BG; Liang LJ; Hua YP
    BMC Cancer; 2018 Apr; 18(1):460. PubMed ID: 29690860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FAM83H is involved in the progression of hepatocellular carcinoma and is regulated by MYC.
    Kim KM; Park SH; Bae JS; Noh SJ; Tao GZ; Kim JR; Kwon KS; Park HS; Park BH; Lee H; Chung MJ; Moon WS; Sylvester KG; Jang KY
    Sci Rep; 2017 Jun; 7(1):3274. PubMed ID: 28607447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-cell transcriptomics reveals opposing roles of Shp2 in Myc-driven liver tumor cells and microenvironment.
    Chen WS; Liang Y; Zong M; Liu JJ; Kaneko K; Hanley KL; Zhang K; Feng GS
    Cell Rep; 2021 Nov; 37(6):109974. PubMed ID: 34758313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KPT-330 inhibitor of XPO1-mediated nuclear export has anti-proliferative activity in hepatocellular carcinoma.
    Zheng Y; Gery S; Sun H; Shacham S; Kauffman M; Koeffler HP
    Cancer Chemother Pharmacol; 2014 Sep; 74(3):487-95. PubMed ID: 25030088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis.
    Bai HY; Liao YJ; Cai MY; Ma NF; Zhang Q; Chen JW; Zhang JX; Wang FW; Wang CY; Chen WH; Jin XH; Xu RH; Guan XY; Xie D
    Stem Cells; 2018 Feb; 36(2):180-191. PubMed ID: 29119708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation.
    Mu H; Yu G; Li H; Wang M; Cui Y; Zhang T; Song T; Liu C
    Cell Oncol (Dordr); 2021 Oct; 44(5):1151-1166. PubMed ID: 34339013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ABL1, Overexpressed in Hepatocellular Carcinomas, Regulates Expression of NOTCH1 and Promotes Development of Liver Tumors in Mice.
    Wang F; Hou W; Chitsike L; Xu Y; Bettler C; Perera A; Bank T; Cotler SJ; Dhanarajan A; Denning MF; Ding X; Breslin P; Qiang W; Li J; Koleske AJ; Qiu W
    Gastroenterology; 2020 Jul; 159(1):289-305.e16. PubMed ID: 32171747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis.
    Bozkaya G; Korhan P; Cokaklı M; Erdal E; Sağol O; Karademir S; Korch C; Atabey N
    Mol Cancer; 2012 Sep; 11():64. PubMed ID: 22962849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SRC-2-mediated coactivation of anti-tumorigenic target genes suppresses MYC-induced liver cancer.
    Suresh S; Durakoglugil D; Zhou X; Zhu B; Comerford SA; Xing C; Xie XJ; York B; O'Donnell KA
    PLoS Genet; 2017 Mar; 13(3):e1006650. PubMed ID: 28273073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focal adhesion kinase activation limits efficacy of Dasatinib in c-Myc driven hepatocellular carcinoma.
    Liu X; Song X; Zhang J; Xu Z; Che L; Qiao Y; Ortiz Pedraza Y; Cigliano A; Pascale RM; Calvisi DF; Liu Y; Chen X
    Cancer Med; 2018 Dec; 7(12):6170-6181. PubMed ID: 30370649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AGO2 Mediates
    Zhang K; Pomyen Y; Barry AE; Martin SP; Khatib S; Knight L; Forgues M; Dominguez DA; Parhar R; Shah AP; Bodzin AS; Wang XW; Dang H
    Mol Cancer Res; 2020 Apr; 18(4):612-622. PubMed ID: 31941754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells.
    Li SG; Shi QW; Yuan LY; Qin LP; Wang Y; Miao YQ; Chen Z; Ling CQ; Qin WX
    J Exp Clin Cancer Res; 2018 Mar; 37(1):51. PubMed ID: 29523159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aurora kinase A mediates c-Myc's oncogenic effects in hepatocellular carcinoma.
    Lu L; Han H; Tian Y; Li W; Zhang J; Feng M; Li Y
    Mol Carcinog; 2015 Nov; 54(11):1467-79. PubMed ID: 25284017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin E.
    Tu K; Zheng X; Zhou Z; Li C; Zhang J; Gao J; Yao Y; Liu Q
    PLoS One; 2013; 8(7):e68574. PubMed ID: 23840897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of combined hepatocellular-cholangiocarcinoma through transdifferentiation and dedifferentiation in p53-knockout mice.
    Liu Y; Xin B; Yamamoto M; Goto M; Ooshio T; Kamikokura Y; Tanaka H; Meng L; Okada Y; Mizukami Y; Nishikawa Y
    Cancer Sci; 2021 Aug; 112(8):3111-3124. PubMed ID: 34051011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression profiling of MYC-driven tumor signatures in porcine liver stem cells by transcriptome sequencing.
    Aravalli RN; Talbot NC; Steer CJ
    World J Gastroenterol; 2015 Feb; 21(7):2011-29. PubMed ID: 25717234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer.
    Ladu S; Calvisi DF; Conner EA; Farina M; Factor VM; Thorgeirsson SS
    Gastroenterology; 2008 Oct; 135(4):1322-32. PubMed ID: 18722373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of MYC-induced tumorigenesis by in situ lipid profiling.
    Perry RH; Bellovin DI; Shroff EH; Ismail AI; Zabuawala T; Felsher DW; Zare RN
    Anal Chem; 2013 May; 85(9):4259-62. PubMed ID: 23560736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.